March 18th, 2015
August 2016: The Second Circuit Court of Appeals vacated the District Court’s decision to dismiss the case and remanded the case for further proceedings. (Nicosia et al v. Amazon.com, Inc., Case No. 15-423, 2nd Cir.) February 2015: A federal judge dismissed this lawsuit finding, among other things, that the plaintiff waived his right to bring
February 7th, 2017
FDA alerts consumers to banned ingredient in weight-loss supplement.
December 28th, 2016
FDA alerts supplement marketer to a laundry list of violations.
June 14th, 2016
Hidden ingredients pose serious health risks, FDA warns supplement maker.
November 3rd, 2014
New report finds that recalled supplements containing hidden drugs are still available for purchase online.
October 30th, 2014
The FDA’s message to the makers of the dietary supplement is simple: Shape up or ship out.
July 2nd, 2014
Agency issues warning to consumers not to use this product.
January 22nd, 2014
FDA warns consumers about weight-loss product containing hidden drug ingredients.
October 23rd, 2013
The FDA has issued a warning letter to Dolphin Intertrade Corporation because the company is allegedly marketing supplements that contain an unapproved prescription drug ingredient. According to the FDA, Dolphin markets the supplements Jadera and Xiyouji Qingzhi with the following intended uses: “Lose Weight Effectively” “Keep the Weight off” “Curb Your Appetite” “Burn the Fat
June 27th, 2013
The FDA is advising consumers to avoid “Strawberry Balance,” a product sold for weight-loss that was found to contain hidden drug ingredients. According to the FDA, FDA laboratory analysis confirmed that “Strawberry Balance” contains sibutramine. Sibutramine can substantially increase blood pressure and pulse rate, and can present a danger to patients with heart or circulation
June 27th, 2013
The FDA is advising consumers to avoid “Meizi Evolution,” a product sold for weight-loss that was found to contain a hidden drug ingredient. According to the FDA, FDA laboratory analysis confirmed that “Meizi Evolution” contains sibutramine. Sibutramine can substantially increase blood pressure and pulse rate, and can present a danger to patients with heart or
June 18th, 2013
The FDA is telling consumers to stay away from Fat Zero, a supplement sold for weight loss that contains hidden drug ingredients sibutramine and phenolphthalein. Sibutramine was removed from the market in 2010 after being linked to increased blood pressure and pulse rate. Phenolphthalein was an ingredient in over-the-counter laxatives until 1999, when the FDA
February 28th, 2013
P&J Trading is conducting a voluntary recall of Slimdia Revolution, a line of diet supplements. The supplements contain an ingredient called Sibutramine, which is an FDA-approved appetite suppressant to treat obesity, which is only supposed to be taken under medical supervision. It is not listed on the label for the products and is not sold